# Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

> **NCT00037843** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 114 (actual)

## Conditions studied

- Adrenal Gland Diseases
- Adrenal Gland Neoplasms

## Interventions

- **DRUG:** I-131 Iodocholesterol

## Key facts

- **NCT ID:** NCT00037843
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1988-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2012-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037843, "Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00037843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*